Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
News: Latest News
Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors

Portnoy Law Firm: Bellus Health Inc. Investors Last Days to Participate Actively in the Class Action Lawsuit

05/07/2021 | 02:06pm EDT

Investors with losses are encouraged to contact the firm before May 17, 2021; click here to submit trade information

​LOS ANGELES, May 07, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises investors that a class action lawsuit has been filed on behalf of Bellus Health, Inc. (NASDAQ: BLU) investors that acquired shares between September 5, 2019 and July 5, 2020. Investors have until May 17, 2021 to seek an active role in this litigation.

Investors are encouraged to contact attorney Lesley F. Portnoy, to determine eligibility to participate in this action, by phone 310-692-8883 or email, or click here to join the case.

Before the market opened on July 6, 2020, BELLUS announced topline results from its Phase 2 RELIEF trial of BLU-5937 in patients with refractory chronic cough. According to Bellus, the trial “did not achieve statistical significance for the primary endpoint of reduction in placebo-adjusted cough frequency at any dose tested.”

Bellus’ stock price fell $9.05, or 75%, on this news, over two consecutive trading sessions to close at $2.97 on July 8, 2020, thereby injuring investors.

It is alleged in this complaint that Bellus made materially misleading and/or false statements, as well as failed to disclose material adverse facts about Bellus’ business, operations, and prospects. Specifically, the complaint alleges that Bellus knew, and failed to disclose, that while BLU-5937’s “high selectivity” contributed to the drug causing little to no taste alteration in chronic cough patients, high selectivity also contributed to the drug potentially being less efficacious and thus likely not be able to meet the primary endpoint of the Company’s Phase 2 trial.

A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than May 17, 2021.

Please visit our website to review more information and submit your transaction information.

The Portnoy Law Firm represents investors in pursuing claims arising from corporate wrongdoing. The Firm’s founding partner has recovered over $5.5 billion for aggrieved investors. Attorney advertising. Prior results do not guarantee similar outcomes.

Lesley F. Portnoy, Esq.
Admitted CA and NY Bar
lesley@portnoylaw.com
310-692-8883
www.portnoylaw.com

Attorney Advertising


Primary Logo


© GlobeNewswire 2021
Latest news "Companies"
05:58pSUN LIFE FINANCIAL  : announces offering of Limited Recourse Capital Notes
PR
05:57pDEAN ARMSTRONG : What International Women in Engineering Day means to us
PU
05:57pCarrols Restaurant Group, Inc. Prices Offering of $300 Million of Senior Notes Due 2029
GL
05:56pNFL explores strategic partnership for media assets
RE
05:56pAMAZON COM  : NFL explores strategic partnership for media assets
RE
05:55pGEAR ENERGY LTD.  : Announces Successful Completion of Annual Borrowing Base Redetermination and May Update to Shareholders
AQ
05:55pAether Catalyst Solutions Announces First Tranche of Non-Brokered Private Placement
NE
05:54pMCAFEE  : Anti-virus software pioneer John McAfee found dead in Spanish prison cell
AQ
05:53pAGORA  : Building an Android Video Chat App with In-Call Statistics
PU
05:52pSILVERGATE CAPITAL  : Announces Virtual Participation at Compass Point's Cryptocurrency & Blockchain Day
BU
Latest news "Companies"